192 related articles for article (PubMed ID: 20500832)
1. Fluvastatin in the first-line therapy of acute coronary syndrome: results of the multicenter, randomized, double-blind, placebo-controlled trial (the FACS-trial).
Ostadal P; Alan D; Vejvoda J; Kukacka J; Macek M; Hajek P; Mates M; Kvapil M; Kettner J; Wiendl M; Aschermann O; Slaby J; Holm F; Telekes P; Horak D; Blasko P; Zemanek D; Veselka J; Cepova J
Trials; 2010 May; 11():61. PubMed ID: 20500832
[TBL] [Abstract][Full Text] [Related]
2. Fluvastatin in the therapy of acute coronary syndrome: Rationale and design of a multicenter, randomized, double-blind, placebo-controlled trial (The FACS Trial)[ISRCTN81331696].
Ostadal P; Alan D; Hajek P; Vejvoda J; Mates M; Blasko P; Veselka J; Kvapil M; Kettner J; Wiendl M; Aschermann O; Slaby J; Nemecek E; Holm F; Rac M; Macek M; Cepova J
Curr Control Trials Cardiovasc Med; 2005 Mar; 6(1):4. PubMed ID: 15790413
[TBL] [Abstract][Full Text] [Related]
3. Fluvastatin and perioperative events in patients undergoing vascular surgery.
Schouten O; Boersma E; Hoeks SE; Benner R; van Urk H; van Sambeek MR; Verhagen HJ; Khan NA; Dunkelgrun M; Bax JJ; Poldermans D;
N Engl J Med; 2009 Sep; 361(10):980-9. PubMed ID: 19726772
[TBL] [Abstract][Full Text] [Related]
4. Effects of fluvastatin extended-release (80 mg) alone and in combination with ezetimibe (10 mg) on low-density lipoprotein cholesterol and inflammatory parameters in patients with primary hypercholesterolemia: a 12-week, multicenter, randomized, open-label, parallel-group study.
Alvarez-Sala LA; Cachofeiro V; Masana L; Suarez C; Pinilla B; Plana N; Trias F; Moreno MA; Gambus G; Lahera V; Pintó X
Clin Ther; 2008 Jan; 30(1):84-97. PubMed ID: 18343245
[TBL] [Abstract][Full Text] [Related]
5. Randomized, double-blind, placebo-controlled comparison of the action of orlistat, fluvastatin, or both an anthropometric measurements, blood pressure, and lipid profile in obese patients with hypercholesterolemia prescribed a standardized diet.
Derosa G; Mugellini A; Ciccarelli L; Fogari R
Clin Ther; 2003 Apr; 25(4):1107-22. PubMed ID: 12809960
[TBL] [Abstract][Full Text] [Related]
6. A randomized placebo-controlled trial of fluvastatin for prevention of restenosis after successful coronary balloon angioplasty; final results of the fluvastatin angiographic restenosis (FLARE) trial.
Serruys PW; Foley DP; Jackson G; Bonnier H; Macaya C; Vrolix M; Branzi A; Shepherd J; Suryapranata H; de Feyter PJ; Melkert R; van Es GA; Pfister PJ
Eur Heart J; 1999 Jan; 20(1):58-69. PubMed ID: 10075142
[TBL] [Abstract][Full Text] [Related]
7. Long-term cardiac outcomes in renal transplant recipients receiving fluvastatin: the ALERT extension study.
Holdaas H; Fellström B; Cole E; Nyberg G; Olsson AG; Pedersen TR; Madsen S; Grönhagen-Riska C; Neumayer HH; Maes B; Ambühl P; Hartmann A; Staffler B; Jardine AG;
Am J Transplant; 2005 Dec; 5(12):2929-36. PubMed ID: 16303007
[TBL] [Abstract][Full Text] [Related]
8. Effect of fluvastatin on cardiac outcomes in kidney transplant patients with systemic lupus erythematosus: a randomized placebo-controlled study.
Norby GE; Holme I; Fellström B; Jardine A; Cole E; Abedini S; Holdaas H;
Arthritis Rheum; 2009 Apr; 60(4):1060-4. PubMed ID: 19333947
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the efficacy and tolerability of fluvastatin extended-release and immediate-release formulations in the treatment of primary hypercholesterolemia: a randomized trial.
Olsson AG; Pauciullo P; Soska V; Luley C; Pieters RE; Broda G; Palacios B;
Clin Ther; 2001 Jan; 23(1):45-61. PubMed ID: 11219479
[TBL] [Abstract][Full Text] [Related]
10. The effect of different doses of fluvastatin on inflammatory markers in the early phase of acute coronary syndrome.
Yang J; Li XP; Zhao SP; Li J; Li JD; Xie XM
Clin Chim Acta; 2006 Jun; 368(1-2):183-7. PubMed ID: 16472797
[TBL] [Abstract][Full Text] [Related]
11. Relationship between inflammation and benefits of early high-dose rosuvastatin on contrast-induced nephropathy in patients with acute coronary syndrome: the pathophysiological link in the PRATO-ACS study (Protective Effect of Rosuvastatin and Antiplatelet Therapy on Contrast-Induced Nephropathy and Myocardial Damage in Patients With Acute Coronary Syndrome Undergoing Coronary Intervention).
Toso A; Leoncini M; Maioli M; Tropeano F; Di Vincenzo E; Villani S; Bellandi F
JACC Cardiovasc Interv; 2014 Dec; 7(12):1421-9. PubMed ID: 25523533
[TBL] [Abstract][Full Text] [Related]
12. Effect of acetaminophen and fluvastatin on post-dose symptoms following infusion of zoledronic acid.
Silverman SL; Kriegman A; Goncalves J; Kianifard F; Carlson T; Leary E
Osteoporos Int; 2011 Aug; 22(8):2337-45. PubMed ID: 21116816
[TBL] [Abstract][Full Text] [Related]
13. Comparison of fluvastatin + fenofibrate combination therapy and fluvastatin monotherapy in the treatment of combined hyperlipidemia, type 2 diabetes mellitus, and coronary heart disease: a 12-month, randomized, double-blind, controlled trial.
Derosa G; Cicero AE; Bertone G; Piccinni MN; Ciccarelli L; Roggeri DE
Clin Ther; 2004 Oct; 26(10):1599-607. PubMed ID: 15598476
[TBL] [Abstract][Full Text] [Related]
14. The effect of fluvastatin on cardiac events in patients with symptomatic coronary artery disease during one year of treatment.
Riegger G; Abletshauser C; Ludwig M; Schwandt P; Widimsky J; Weidinger G; Welzel D
Atherosclerosis; 1999 May; 144(1):263-70. PubMed ID: 10381299
[TBL] [Abstract][Full Text] [Related]
15. Reduced P-selectin in hearts pretreated with fluvastatin: a novel benefit for patients undergoing open heart surgery.
Berkan O; Katrancioglu N; Ozker E; Ozerdem G; Bakici Z; Yilmaz MB
Thorac Cardiovasc Surg; 2009 Mar; 57(2):91-5. PubMed ID: 19241310
[TBL] [Abstract][Full Text] [Related]
16. Fluvastatin administration at bedtime versus with the evening meal: a multicenter comparison of bioavailability, safety, and efficacy.
Dujovne CA; Davidson MH
Am J Med; 1994 Jun; 96(6A):37S-40S. PubMed ID: 8017465
[TBL] [Abstract][Full Text] [Related]
17. [The effect of early fluvastatin therapy on inflammatory factors in acute coronary syndrome].
Yang J; Li XP; Zhao SP; Li J; Li JD; Xie XM; Peng J
Zhonghua Nei Ke Za Zhi; 2005 Mar; 44(3):184-7. PubMed ID: 15840256
[TBL] [Abstract][Full Text] [Related]
18. Early, intensive statin treatment reduces 'hard' cardiovascular outcomes after acute coronary syndrome.
Schwartz GG; Fayyad R; Szarek M; DeMicco D; Olsson AG
Eur J Prev Cardiol; 2017 Aug; 24(12):1294-1296. PubMed ID: 28504565
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and tolerability of fluvastatin XL 80 mg alone, ezetimibe alone, and the combination of fluvastatin XL 80 mg with ezetimibe in patients with a history of muscle-related side effects with other statins.
Stein EA; Ballantyne CM; Windler E; Sirnes PA; Sussekov A; Yigit Z; Seper C; Gimpelewicz CR
Am J Cardiol; 2008 Feb; 101(4):490-6. PubMed ID: 18312764
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of once-daily vs twice-daily dosing with fluvastatin, a synthetic reductase inhibitor, in primary hypercholesterolemia.
Insull W; Black D; Dujovne C; Hosking JD; Hunninghake D; Keilson L; Knopp R; McKenney J; Stein E; Troendle AJ
Arch Intern Med; 1994 Nov; 154(21):2449-55. PubMed ID: 7979841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
